AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21897852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 19647921 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg atorvastatin daily
Number of subjects: 35
Study 19647921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 17465940 — intervention group
Group type: EXPERIMENTAL
Intervention: Tag on blood bags reminding staff to check the patient's wristband
Number of subjects: 15
Study 17465940 — intervention group
Group type: COMPARATOR
Intervention: Control group (baseline audit period)
Number of subjects: 15
Study 15085090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol influx (40 g bolus infusion)
Number of subjects: 20
Study 15085090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol elimination phase
Number of subjects: 20
Study 15085090 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 20
Study 12196616 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer counseling
Number of subjects: 794
Study 12196616 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 794
Study 12196616 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant-parent contingency contract intervention
Number of subjects: 794
Study 10436958 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuezhikang (4 capsules/day, 1.2 g/day for 8 weeks)
Number of subjects: 108
Study 10436958 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (Zocor, 10 mg/day for 8 weeks)
Number of subjects: 108
Study 7635024 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine iron supplements during pregnancy
Number of subjects: 0
Study 7635024 — intervention group
Group type: COMPARATOR
Intervention: No iron supplements during pregnancy
Number of subjects: 0
Study 3284601 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Muscular Relaxation (PMR)
Number of subjects: 100
Study 3284601 — intervention group
Group type: COMPARATOR
Intervention: Control group (short visit)
Number of subjects: 100
Study 30376124 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized Metacognitive Training (MCT+)
Number of subjects: 54
Study 30376124 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Remediation (CR)
Number of subjects: 54
Study 27856432 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarilumab (200 mg every 2 weeks)
Number of subjects: 0
Study 27856432 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab (40 mg every 2 weeks)
Number of subjects: 0
Study 27856432 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarilumab
Number of subjects: 0
Study 27856432 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 0
Study 25604769 — intervention group
Group type: EXPERIMENTAL
Intervention: ω3 plus low‐dose aspirin for 6 months
Number of subjects: 40
Study 25604769 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 40
Study 23100188 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscosupplementation with triamcinolone (Group VS + T)
Number of subjects: 104
Study 23100188 — intervention group
Group type: COMPARATOR
Intervention: Viscosupplementation alone (Group VS)
Number of subjects: 104
Study 21859055 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural restrictions after canalith repositioning maneuver (CRM)
Number of subjects: 74
Study 21859055 — intervention group
Group type: COMPARATOR
Intervention: No postural restrictions after canalith repositioning maneuver (CRM)
Number of subjects: 74
Study 19332209 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine or regadenoson administration
Number of subjects: 2000
Study 19332209 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 2000
Study 19332209 — intervention group
Group type: COMPARATOR
Intervention: DM status
Number of subjects: 2000
Study 16968790 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrabrachial acetylcholine (Ach) (0.15-15 microg/min.dl) with local vascular COX inhibition by intrabrachial indomethacin (50 microg/min.dl)
Number of subjects: 53
Study 16968790 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic nonselective COX inhibition (100 mg indomethacin)
Number of subjects: 53
Study 16968790 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective COX-2 blockade (200 mg celecoxib)
Number of subjects: 53
Study 16968790 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (8 mg/min.dl)
Number of subjects: 53
Study 16968790 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside
Number of subjects: 53
Study 16968790 — intervention group
Group type: COMPARATOR
Intervention: L-NMMA (100 microg/min.dl)
Number of subjects: 53
Study 15517116 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone 50 to 150 mg daily
Number of subjects: 133
Study 11393553 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 days intravenous insulin infusion annually followed by b.i.d. low doses of subcutaneous ultralente insulin
Number of subjects: 552
Study 11393553 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral insulin
Number of subjects: 552
Study 11393553 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide
Number of subjects: 552
Study 11393553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 552
Study 9236642 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal perineal massage
Number of subjects: 861
Study 8003918 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG model sources associated with abstract thoughts
Number of subjects: 12
Study 8003918 — intervention group
Group type: COMPARATOR
Intervention: EEG model sources associated with visual imagery
Number of subjects: 12
Study 2885639 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% glucose polymer solution (302 mOsm/kg)
Number of subjects: 0
Study 2885639 — intervention group
Group type: COMPARATOR
Intervention: 1.36% glucose solution (332 mOsm/kg)
Number of subjects: 0
Study 2885639 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% glucose polymer solution
Number of subjects: 0
Study 30941421 — intervention group
Group type: EXPERIMENTAL
Intervention: Caponization (surgical castration)
Number of subjects: 224
Study 27583658 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubeless minimally invasive percutaneous nephrolithotomy (MPCNL)
Number of subjects: 62
Study 27583658 — intervention group
Group type: COMPARATOR
Intervention: Standard percutaneous nephrolithotomy (MPCNL)
Number of subjects: 62
Study 26791478 — intervention group
Group type: EXPERIMENTAL
Intervention: Kundalini yoga programme (15min twice-daily for 12 weeks)
Number of subjects: 191
Study 26791478 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 191
Study 26791478 — intervention group
Group type: EXPERIMENTAL
Intervention: Kundalini yoga programme
Number of subjects: 191
Study 24361280 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib treatment
Number of subjects: 437
Study 24361280 — intervention group
Group type: COMPARATOR
Intervention: Cytology samples
Number of subjects: 437
Study 24361280 — intervention group
Group type: COMPARATOR
Intervention: Histology samples
Number of subjects: 437
Study 24361280 — intervention group
Group type: COMPARATOR
Intervention: Previous analysis
Number of subjects: 437
Study 22620695 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinosad at the manufacturer's recommended dose
Number of subjects: 6
Study 22620695 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 6
Study 18836881 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint Crisis Plans (JCPs)
Number of subjects: 160
Study 17070596 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide treatment
Number of subjects: 1077
Study 17070596 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle of dorzolamide)
Number of subjects: 1077
Study 11996471 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin/etoposide (PE) followed by hyperfractionated accelerated radiotherapy (HF-RTx; 1.5 Gy bid up to a total dose of 45 Gy in 3 weeks) concurrent with one cycle of PE, and a small volume boost of 20 Gy (qd) for a total of 65 Gy to the primary.
Number of subjects: 30
Study 10204726 — intervention group
Group type: COMPARATOR
Intervention: Sham heel prick
Number of subjects: 23
Study 10204726 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharp heel prick
Number of subjects: 23
Study 10204726 — intervention group
Group type: EXPERIMENTAL
Intervention: Squeezing the heel for blood sampling
Number of subjects: 23
Study 7759655 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath sound added to synthetic speech
Number of subjects: 0
Study 7759655 — intervention group
Group type: COMPARATOR
Intervention: Breath sound replaced with rustling leaves
Number of subjects: 0
Study 7759655 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath sound before randomly selected sentences
Number of subjects: 0
Study 7759655 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath sound appropriateness to sentence size
Number of subjects: 0
Study 7759655 — intervention group
Group type: COMPARATOR
Intervention: Breath sound in experiment 5
Number of subjects: 0
Study 2676249 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal sodium intake group (44 subjects receiving less than 80 mmol sodium daily in the diet plus 80 mmol of sodium supplement as eight slow release sodium chloride tablets daily)
Number of subjects: 88
Study 2676249 — intervention group
Group type: COMPARATOR
Intervention: Low sodium intake group (44 subjects receiving less than 80 mmol sodium daily in the diet plus eight slow release sodium chloride placebo tablets daily)
Number of subjects: 88
Study 24357 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg lorazepam via deep intramuscular injection
Number of subjects: 0
Study 24357 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg lorazepam via deep intramuscular injection
Number of subjects: 0
Study 24357 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg lorazepam via intravenous injection
Number of subjects: 0
Study 24357 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg lorazepam via intravenous injection
Number of subjects: 0
Study 24357 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg and 4 mg lorazepam via any route
Number of subjects: 0
Study 30335625 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.050 μg · kg(‐1) · min(‐1) norepinephrine infusion
Number of subjects: 284
Study 30335625 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.075 μg · kg(‐1) · min(‐1) norepinephrine infusion
Number of subjects: 284
Study 30335625 — intervention group
Group type: COMPARATOR
Intervention: 0.025 μg · kg(‐1) · min(‐1) norepinephrine infusion (control)
Number of subjects: 284
Study 28777263 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced retention package (workflow modifications and active patient tracking)
Number of subjects: 761
Study 28777263 — intervention group
Group type: COMPARATOR
Intervention: Control group (no enhanced retention package)
Number of subjects: 761
Study 28777263 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth before ARV pickup
Number of subjects: 761
Study 25754162 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily dose of oral isotretinoin
Number of subjects: 58
Study 25754162 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily dose of oral isotretinoin
Number of subjects: 58
Study 25754162 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens of oral isotretinoin
Number of subjects: 58
Study 24176644 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended release methylphenidate (MPH‐ER) for 24 weeks
Number of subjects: 241
Study 21546612 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (5 mg once daily for 90 days)
Number of subjects: 75
Study 21546612 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelial antioxidant compound (EAC) administration after tadalafil discontinuation for 6 months
Number of subjects: 75
Study 21546612 — intervention group
Group type: COMPARATOR
Intervention: No other treatment during follow-up after tadalafil cessation
Number of subjects: 75
Study 21546612 — intervention group
Group type: COMPARATOR
Intervention: Placebo during follow-up after tadalafil cessation
Number of subjects: 75
Study 19756033 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior 24-h recalls in the morning for school breakfast
Number of subjects: 374
Study 19756033 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior 24-h recalls in the afternoon for school lunch
Number of subjects: 374
Study 19756033 — intervention group
Group type: COMPARATOR
Intervention: Retention interval effect on accuracy
Number of subjects: 374
Study 17517855 — intervention group
Group type: EXPERIMENTAL
Intervention: Pubovaginal sling using autologous rectus fascia
Number of subjects: 655
Study 17517855 — intervention group
Group type: COMPARATOR
Intervention: Burch colposuspension
Number of subjects: 655
Study 15066454 — intervention group
Group type: COMPARATOR
Intervention: Daily 150 IU recombinant hFSH
Number of subjects: 0
Study 15066454 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent 450 IU recombinant hFSH (3-day intervals)
Number of subjects: 0
Study 11323351 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 16
Study 9753341 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-based TPN (100% glucose)
Number of subjects: 66
Study 9753341 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based TPN (80% lipid, 20% glucose)
Number of subjects: 66
Study 9753341 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 66
Study 7996375 — intervention group
Group type: EXPERIMENTAL
Intervention: Theo-Dur
Number of subjects: 38
Study 7996375 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic slow-release theophylline tablet
Number of subjects: 38
Study 2651576 — intervention group
Group type: EXPERIMENTAL
Intervention: PAF (doxorubicin, melphalan, fluorouracil)
Number of subjects: 1813
Study 2651576 — intervention group
Group type: EXPERIMENTAL
Intervention: PFT (doxorubicin, fluorouracil, tamoxifen)
Number of subjects: 1813
Study 2651576 — intervention group
Group type: COMPARATOR
Intervention: PF (doxorubicin, fluorouracil)
Number of subjects: 1813
Study 2651576 — intervention group
Group type: COMPARATOR
Intervention: PAFT (doxorubicin, melphalan, fluorouracil, tamoxifen)
Number of subjects: 1813
Study 814956 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 118
Study 814956 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenformin
Number of subjects: 118
Study 814956 — intervention group
Group type: COMPARATOR
Intervention: Diet
Number of subjects: 118
Study 31821732 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaratumab (15 mg/kg) + Doxorubicin (75 mg/m2)
Number of subjects: 49
Study 31821732 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaratumab (20 mg/kg) + Doxorubicin (75 mg/m2)
Number of subjects: 49
Study 30819989 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling (2 antenatal and 8 postpartum home counseling visits by counselors)
Number of subjects: 300
Study 30819989 — intervention group
Group type: COMPARATOR
Intervention: Non-counseling (Control)
Number of subjects: 300
Study 27991804 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive anticipated affect manipulation
Number of subjects: 98
Study 27991804 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative anticipated affect manipulation
Number of subjects: 98
Study 27991804 — intervention group
Group type: COMPARATOR
Intervention: No affect manipulation control
Number of subjects: 98
Study 25962070 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparkling white wine (340 mL; 30 g alcohol) in unpleasant ambiance
Number of subjects: 28
Study 25962070 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparkling white wine (340 mL; 30 g alcohol) in pleasant ambiance
Number of subjects: 28
Study 25962070 — intervention group
Group type: COMPARATOR
Intervention: Alcohol-free sparkling white wine (340 mL; <2 g alcohol) in unpleasant ambiance
Number of subjects: 28
Study 25962070 — intervention group
Group type: COMPARATOR
Intervention: Alcohol-free sparkling white wine (340 mL; <2 g alcohol) in pleasant ambiance
Number of subjects: 28
Study 24330784 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pitch dual-source CT scan mode
Number of subjects: 110
Study 24330784 — intervention group
Group type: COMPARATOR
Intervention: Conventional dual-source CT scan mode
Number of subjects: 110
Study 21520432 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV) plus inhaled nitric oxide (iNO)
Number of subjects: 28
Study 21520432 — intervention group
Group type: COMPARATOR
Intervention: Pressure-controlled assist/control ventilation (PCACV) plus inhaled nitric oxide (iNO)
Number of subjects: 28
Study 19389793 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg mifepristone every other day for 3 months
Number of subjects: 30
Study 19389793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 18261860 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment for alcohol dependence
Number of subjects: 102
Study 18261860 — intervention group
Group type: COMPARATOR
Intervention: Follow-up assessments
Number of subjects: 102
Study 14984854 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer's lactate
Number of subjects: 40
Study 14984854 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% albumin
Number of subjects: 40
Study 14984854 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% dextran 70
Number of subjects: 40
Study 14984854 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hetastarch
Number of subjects: 40
Study 11480805 — intervention group
Group type: EXPERIMENTAL
Intervention: Target-absent photo lineup administered by interviewers who were misinformed about the thief's position.
Number of subjects: 52
Study 11480805 — intervention group
Group type: EXPERIMENTAL
Intervention: Testimonies of Experiment 1 witnesses viewed by participant jurors (n = 80).
Number of subjects: 52
Study 9930385 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg daily)
Number of subjects: 14
Study 9930385 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole (20 mg daily)
Number of subjects: 14
Study 8047572 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 37
Study 8047572 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 37
Study 8047572 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 37
Study 8047572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 2968267 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 40
Study 2968267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 30645203 — intervention group
Group type: EXPERIMENTAL
Intervention: BIIB059
Number of subjects: 12
Study 29638147 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mEq magnesium L-lactate dihydrate under fasting conditions
Number of subjects: 0
Study 29638147 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mEq magnesium L-lactate dihydrate under fed conditions
Number of subjects: 0
Study 29638147 — intervention group
Group type: COMPARATOR
Intervention: IV infusion of 20 mEq magnesium sulfate
Number of subjects: 0
Study 27533046 — intervention group
Group type: EXPERIMENTAL
Intervention: M01ZH09
Number of subjects: 99
Study 27533046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 27533046 — intervention group
Group type: EXPERIMENTAL
Intervention: Ty21a
Number of subjects: 99
Study 27533046 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-existing anti-Vi antibody
Number of subjects: 99
Study 24962503 — intervention group
Group type: EXPERIMENTAL
Intervention: Call + text message
Number of subjects: 584
Study 24962503 — intervention group
Group type: EXPERIMENTAL
Intervention: Documenting a confidential phone number
Number of subjects: 584
Study 24962503 — intervention group
Group type: COMPARATOR
Intervention: Texting only or type of card
Number of subjects: 584
Study 24962503 — intervention group
Group type: EXPERIMENTAL
Intervention: Call + text message with documented confidential phone number
Number of subjects: 584
Study 24962503 — intervention group
Group type: COMPARATOR
Intervention: Call or text message (other combinations)
Number of subjects: 584
Study 22779380 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial soft caries removal at enamel-dentine junction (EDJ) by spoon excavation
Number of subjects: 276
Study 22779380 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete soft caries removal by spoon excavation
Number of subjects: 276
Study 22779380 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional caries removal by steel burs
Number of subjects: 276
Study 19157423 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglytone
Number of subjects: 100
Study 19157423 — intervention group
Group type: COMPARATOR
Intervention: Polydioxanone
Number of subjects: 100
Study 17187606 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced nutrition support
Number of subjects: 169
Study 17187606 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition support
Number of subjects: 169
Study 17187606 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 169
Study 15237012 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple transrectal electroejaculations
Number of subjects: 34
Study 15237012 — intervention group
Group type: COMPARATOR
Intervention: Single transrectal electroejaculation
Number of subjects: 34
Study 15237012 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall fertilization rate after ICSI
Number of subjects: 34
Study 15237012 — intervention group
Group type: EXPERIMENTAL
Intervention: Sperm retrieval success rate
Number of subjects: 34
Study 15237012 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of oocytes retrieved and injected
Number of subjects: 34
Study 11781912 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg droperidol intramuscularly
Number of subjects: 29
Study 11781912 — intervention group
Group type: COMPARATOR
Intervention: 1.5 mg/kg meperidine intramuscularly
Number of subjects: 29
Study 9831973 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (300 mg daily)
Number of subjects: 100
Study 9831973 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg daily)
Number of subjects: 100
Study 9831973 — intervention group
Group type: COMPARATOR
Intervention: Fenofibrate
Number of subjects: 100